Patent application number | Description | Published |
20120252725 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as amino-transferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 10-04-2012 |
20140309165 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as amino-transferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 10-16-2014 |
20150051145 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as aminotransferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 02-19-2015 |
20150352065 | METHODS OF TREATMENT OF FIBROSIS AND CANCERS - The present invention relates to the use of compound 1-[4-methylthiophenyl]-3-[3,5-dimethyl-4-carboxydimethyl-methyloxyphenyl]prop-2-en-1-one for treating fibrotic diseases and cancers. | 12-10-2015 |
20160051501 | USE OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES FOR TREATING LIVER DISORDERS - The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as aminotransferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease. | 02-25-2016 |
Patent application number | Description | Published |
20160050062 | System and Method for Radio Full Duplex - In one embodiment, a method for calibrating a full-duplex radio system includes transmitting, by a first radio transmitter, a first signal and receiving, by a first radio receiver, a first version of the first signal. The method also includes receiving, by a second radio receiver, a second version of the first signal and transmitting, by a second radio transmitter, a second signal. Additionally, the method includes receiving, by the first radio receiver, a received version of the second signal and determining a response from the second radio transmitter to the first radio receiver in accordance with the first version of the first signal, the second version of the first signal, and the received version of the second signal. | 02-18-2016 |
20160094332 | Systems and Methods for Analog Cancellation for Division Free Duplexing for Radios Using MIMO - System and method embodiments are provided for analog cancellation for division free duplexing for radios using MIMO. In an embodiment, a system for minimizing transmitted signals from a transmitter appearing at a co-located receiver in a division free duplexing radio includes a transmitter to transmit an analog transmitted signal; an antenna; a circulator coupled to the transmitter and the antenna; a tuning algorithm component configured to receive a copy of the analog transmitted signal from the transmitter and a sampled analog received signal from a received signal path from the circulator, wherein the sampled analog received signal is sampled at a point in the received signal path before the analog received signal is provided to a receiver; and a multitap cancellation component configured to provide a cancellation signal to couple to the analog received signal such that an amount of the analog transmitted signal appearing at the receiver is reduced. | 03-31-2016 |
20160105272 | Systems and Methods for Leak Suppression in a Full Duplex System - A system and method for leak suppression in a full duplex system is disclosed. In an embodiment, a system for wireless transmission and reception includes a circulator having a common port, an input port and an output port; a conjugate matching tuner coupled to the common port; and an antenna coupled to the conjugate matching tuner, an impedance of the antenna being conjugate matched to an impedance of the common port of the circulator by the conjugate matching tuner. | 04-14-2016 |
Patent application number | Description | Published |
20090012010 | Amino acid derivatives as calcium channel blockers - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds containing both an amino acid functionality and multiple aromatic rings are disclosed of the general formula (1) where X is benzhydryl, or an aromatic or heteroaromatic ring. | 01-08-2009 |
20090221603 | HETEROCYCLIC AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type or T-type calcium channel activity are disclosed. Specifically, a series of heterocyclic amides are disclosed of the general formula (1) where Z is N or ═CHNR | 09-03-2009 |
20090270338 | DIARYL-CYCLYLALKYL DERIVATIVES AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of substituted or unsubstituted N-cyclylalkyl-diphenylpropanamide derivatives as shown in formula (1). | 10-29-2009 |
20090270394 | CYCLYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of substituted or unsubstituted cyclylamine derivatives as shown in formulas (1). | 10-29-2009 |
20090270413 | DI-T-BUTYLPHENYL PIPERAZINES AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds containing di-t-butyl phenyl piperazine derivatives of the general formula (1). | 10-29-2009 |
20100168103 | DIARYL PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type calcium channel activity are disclosed. Specifically, a series of diaryl piperidine compounds are disclosed of the general formula (I) where X is a linker and Y may be C, O, S or N. | 07-01-2010 |
Patent application number | Description | Published |
20150303793 | POINT OF LOAD REGULATOR SYNCHRONIZATION AND PHASE OFFSET - An electronic system includes a multiple POL regulators that supply a regulated voltage to a component within the electronic system. A phase spreading scheme may be implemented so that the POL regulators operate under various phases to reduce voltage noise, high input capacitance, and high radiated emissions. One phase spreading scheme includes a single POL regulator controlling phase spreading so that the other POL regulators operate under different phases. Another phase spreading scheme includes an upstream POL regulator determining a phase offset that may be passed to a downstream POL regulator so that the downstream POL regulator may operate under a different phase relative to the upstream POL regulator. | 10-22-2015 |
20150362167 | LIGHT PIPE HEAT SINK ELEMENT - An assembly for use with a heat producing electronic device is disclosed. The assembly may include a heat sink in thermally conductive contact with a shell containing the electronic device, and a light pipe having a first thermal conductivity and configured to transmit light from a light-emitting diode (LED) to a front side of the heat sink. The light pipe may include at least a portion having a thermally conductive layer with a second thermal conductivity greater than the first thermal conductivity. The thermally conductive layer may cover at least a portion of an outer surface of the light pipe, and be positioned between, and in thermally conductive contact with a portion of the heat sink protrusions. The thermally conductive layer may be designed to conduct and radiate heat away from at least a portion of the heat sink protrusions. | 12-17-2015 |
20160116149 | LIGHT PIPE HEAT SINK ELEMENT - An assembly for use with a heat producing electronic device is disclosed. The assembly may include a heat sink in thermally conductive contact with a shell containing the electronic device, and a light pipe having a first thermal conductivity and configured to transmit light from a light-emitting diode (LED) to a front side of the heat sink. The light pipe may include at least a portion having a thermally conductive layer with a second thermal conductivity greater than the first thermal conductivity. The thermally conductive layer may cover at least a portion of an outer surface of the light pipe, and be positioned between, and in thermally conductive contact with a portion of the heat sink protrusions. The thermally conductive layer may be designed to conduct and radiate heat away from at least a portion of the heat sink protrusions. | 04-28-2016 |